Richard Tomasini Selected Research

Richard Tomasini Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 10/2007
13	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2013
7	Adenocarcinoma 01/2022 - 03/2013
5	Pancreatitis 01/2020 - 01/2002
5	Carcinogenesis 01/2019 - 01/2009
2	Genomic Instability 01/2009 - 10/2008
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Fibrosis (Cirrhosis) 11/2020
1	Metaplasia 01/2020
1	Male Infertility (Male Sterility) 02/2014
1	Hyperplasia 05/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2011
1	Hydrocephalus (Hydrocephaly) 04/2011
1	Neuroblastoma 04/2011
1	Polyploidy 02/2009
1	Lung Neoplasms (Lung Cancer) 01/2009
1	Infertility (Sterility) 10/2008
1	Chromosomal Instability (Chromosome Stability) 05/2008
1	Hereditary pancreatitis 08/2005
1	Salmonella Infections (Salmonellosis) 07/2004

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2021 - 05/2002
7	Protein Isoforms (Isoforms)IBA 01/2019 - 10/2008
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2015
3	Oxygen (Dioxygen)IBA 01/2022 - 12/2010
2	Peptides (Polypeptides)IBA 01/2021 - 12/2015
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 02/2015
2	pasireotideIBA 01/2021 - 06/2015
2	Transcription Factors (Transcription Factor)IBA 04/2011 - 01/2011
1	3-hydroxy-3-methylglutaryl-coenzyme A lyase (HMG-CoA lyase)IBA 01/2022
1	EnzymesIBA 01/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 09/2021
1	Galectin 1 (LGALS1)IBA 09/2021
1	Biological ProductsIBA 06/2021
1	Vascular Endothelial Growth FactorsIBA 06/2021
1	Nonesterified Fatty Acids (NEFA)IBA 06/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 06/2021
1	Oleic Acid (Oleate)IBA 06/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 11/2020
1	LigandsIBA 01/2020
1	activin AIBA 01/2020
1	Conditioned Culture MediaIBA 11/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Pancreatitis-Associated ProteinsIBA 11/2017
1	CollagenIBA 01/2017
1	Proline (L-Proline)FDA Link 01/2017
1	Annexin A6IBA 11/2016
1	AnnexinsIBA 11/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2016
1	Thrombospondin 1IBA 11/2016
1	Gemcitabine FDA Link 06/2015
1	Small Interfering RNA (siRNA)IBA 02/2015
1	CholesterolIBA 02/2015
1	Lipoproteins (Lipoprotein)IBA 02/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2014
1	Glucagon (Glukagon)FDA Link 05/2013
1	Insulin (Novolin)FDA Link 05/2013
1	HexosaminesIBA 03/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2013
1	Glycoproteins (Glycoprotein)IBA 03/2013
1	Glutamine (L-Glutamine)FDA Link 03/2013
1	CarcinogensIBA 10/2008
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2008
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2007
1	Oncogene Proteins (Oncogene Protein)IBA 10/2007
1	Cisplatin (Platino)FDA LinkGeneric 12/2005
1	TrypsinogenIBA 08/2005
1	CeruletideIBA 07/2004
1	LipopolysaccharidesIBA 07/2004
1	InterferonsIBA 07/2004
1	Messenger RNA (mRNA)IBA 05/2002
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 06/2015 - 03/2010
3	Therapeutics 06/2021 - 04/2011